REPL
NASDAQStockReplimune Group, Inc.
$7.67-0.26 (-3.23%)
52-Week Range
$2.81
$12.63
Key Stats
Market Cap
632.9M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.77
Volume
761.7K
Avg Volume
1.4M
Performance
1M
-2.32%
3M
-23.82%
6M
+33.69%
YTD
-14.83%
1Y
-36.09%
3Y
-61.83%
5Y
-77.73%
Price Chart
ETF Exposure
REPL is held by 63 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About REPL ETF Exposure
Replimune Group, Inc. (REPL) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 632.9M, REPL is a widely held institutional stock. The stock currently trades at $7.67. Investors can gain exposure to REPL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold REPL, sorted by portfolio weight.